Artiva Biotherapeutics (ARTV) Treasury Shares (2023 - 2026)

Artiva Biotherapeutics (ARTV) has 4 years of Treasury Shares data on file, last reported at $4.1 million in Q1 2026.

• On a quarterly basis, Treasury Shares fell 34.09% year-over-year to $4.1 million in Q1 2026; TTM through Mar 2026 was $4.1 million, a 34.09% decrease from a year earlier, with the FY2025 full-year figure at $2.6 million, up 421.07% from the prior year.
• Treasury Shares for Q1 2026 stood at $4.1 million, up from $2.6 million in the prior quarter.
• Over the last five years, Treasury Shares for ARTV reached as high as $6.2 million in Q1 2025 and fell as low as $506845.0 in Q4 2024.
• Historically, Treasury Shares has averaged $3.5 million across 4 years, with a median of $3.7 million in 2023.
• Across the five-year window, Treasury Shares tumbled 79.62% in 2024 and surged 421.07% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $2.5 million in 2023, then tumbled by 79.62% to $506845.0 in 2024, then jumped by 421.07% to $2.6 million in 2025, then surged by 53.73% to $4.1 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $4.1 million in Q1 2026, $2.6 million in Q4 2025, and $6.2 million in Q3 2025.